BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 7861243)

  • 1. Apolipoprotein A-I synthesis and secretion are increased in Hep G2 cells depleted of copper by cupruretic tetramine.
    Zhang JJ; Wang Y; Lei KY
    J Nutr; 1995 Feb; 125(2):172-82. PubMed ID: 7861243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of apolipoprotein A-I gene expression in Hep G2 cells depleted of Cu by cupruretic tetramine.
    Wu JY; Zhang JJ; Wang Y; Reaves SK; Wang YR; Lei PP; Lei KY
    Am J Physiol; 1997 Oct; 273(4):C1362-70. PubMed ID: 9357782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetramine cupruretic agents: a comparison in dogs.
    Allen KG; Twedt DC; Hunsaker HA
    Am J Vet Res; 1987 Jan; 48(1):28-30. PubMed ID: 3826839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copper deficiency and hyperlipoproteinemia induced by a tetramine cupruretic agent in rabbits.
    Hing SA; Lei KY
    Biol Trace Elem Res; 1991 Mar; 28(3):195-211. PubMed ID: 1713043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copper deficiency increases hepatic apolipoprotein A-I synthesis and secretion but does not alter hepatic total cellular apolipoprotein A-I mRNA abundance in rats.
    Hoogeveen RC; Reaves SK; Lei KY
    J Nutr; 1995 Dec; 125(12):2935-44. PubMed ID: 7500171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copper chelating agents. A comparison of cupruretic responses to various tetramines and D-penicillamine.
    Borthwick TR; Benson GD; Schugar HJ
    J Lab Clin Med; 1980 Apr; 95(4):575-80. PubMed ID: 7359013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulse-chase studies of the synthesis of apolipoprotein B in a human hepatoma cell line, Hep G2.
    Wettesten M; Boström K; Bondjers G; Jarfeldt M; Norfeldt PI; Carrella M; Wiklund O; Borén J; Olofsson SO
    Eur J Biochem; 1985 Jun; 149(3):461-6. PubMed ID: 2988946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of retinoic acid on secretion of apolipoproteins A I, A II, B100, C III and E by cultured HepG2 cells].
    Liu H; Wu Z; Liu B
    Hua Xi Yi Ke Da Xue Xue Bao; 2001 Mar; 32(1):52-4. PubMed ID: 12733354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copper deficiency increases hepatic apolipoprotein B secretion and mRNA editing in rats.
    Reaves SK; Hoogeveen RC; Wang YR; Wu JY; Lei KY
    Am J Physiol; 1996 Aug; 271(2 Pt 1):C595-604. PubMed ID: 8770000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of platelet-activating factor, tumor necrosis factor, and interleukin-1alpha on the expression of apolipoprotein M in HepG2 cells.
    Xu N; Zhang XY; Dong X; Ekström U; Ye Q; Nilsson-Ehle P
    Biochem Biophys Res Commun; 2002 Apr; 292(4):944-50. PubMed ID: 11944906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2,3,2-tetramine--a potent cupruretic agent.
    Borthwick TR; Benson GD; Schugar HJ
    Proc Soc Exp Biol Med; 1979 Oct; 162(1):227-8. PubMed ID: 504234
    [No Abstract]   [Full Text] [Related]  

  • 12. Differential effects of insulin and insulin-like growth factor I on the production of plasma steroid-binding globulins by human hepatoblastoma-derived (Hep G2) cells.
    Crave JC; Lejeune H; Brébant C; Baret C; Pugeat M
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1283-9. PubMed ID: 7536204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of 2,3,2-tetramine as a hepatic copper chelating agent for treatment of copper hepatotoxicosis in Bedlington terriers.
    Twedt DC; Hunsaker HA; Allen KG
    J Am Vet Med Assoc; 1988 Jan; 192(1):52-6. PubMed ID: 3343179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of chelators on copper metabolism and copper pools in mouse hepatocytes.
    McArdle HJ; Gross SM; Creaser I; Sargeson AM; Danks DM
    Am J Physiol; 1989 Apr; 256(4 Pt 1):G667-72. PubMed ID: 2705527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Butyrate stimulates the secretion of apolipoprotein A-I and apolipoprotein B-100 in Hep G2 cells by different mechanisms.
    Kaptein A; Roodenburg L; Princen HM
    Clin Biochem; 1992 Oct; 25(5):317-9. PubMed ID: 1337018
    [No Abstract]   [Full Text] [Related]  

  • 16. Transforming growth factor-beta down-regulates apolipoprotein M in HepG2 cells.
    Xu N; Hurtig M; Zhang XY; Ye Q; Nilsson-Ehle P
    Biochim Biophys Acta; 2004 Jul; 1683(1-3):33-7. PubMed ID: 15238217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Octanoate reduces very low-density lipoprotein secretion by decreasing the synthesis of apolipoprotein B in primary cultures of chicken hepatocytes.
    Tachibana S; Sato K; Cho Y; Chiba T; Schneider WJ; Akiba Y
    Biochim Biophys Acta; 2005 Oct; 1737(1):36-43. PubMed ID: 16226916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypolipidemic action of ascofuranone in hepatoblastoma G2 cell culture].
    Trenin AS
    Antibiot Khimioter; 1999; 44(9):7-9. PubMed ID: 10511901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An inhibitor of squalene epoxidase, NB-598, suppresses the secretion of cholesterol and triacylglycerol and simultaneously reduces apolipoprotein B in HepG2 cells.
    Horie M; Hayashi M; Satoh T; Hotta H; Nagata Y; Ishida F; Kamei T
    Biochim Biophys Acta; 1993 May; 1168(1):45-51. PubMed ID: 8504141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of feeding sardine oil on synthesis and secretion of apolipoprotein B-containing lipoproteins by rabbit hepatocytes.
    Anil K; Sudhakaran PR
    Nutrition; 1995; 11(1):17-20. PubMed ID: 7749238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.